ARAY logo

Accuray Incorporated (ARAY)

Profile

Full Name

Accuray Incorporated

Ticker Symbol

ARAY

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Devices

Country

United States

IPO

February 8, 2007

Indexes

Not included

Website

http://www.accuray.com

Employees

987

Key Details

Price

$1.51(+3.43%)

Market cap

$155.28M(Small cap)

Last Dividend

-

TTM Dividend yield

-

Annual revenue

$446.55M(-0.24% YoY)

Annual EPS

-$0.16(-60.00% YoY)

PE ratio

-

Next earnings date

May 1, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$1.51
ARAY price is $1.51

30-Day Relative Volume

1.35
ARAY 30-day relative volume is 1.35

Price Performance

Price Today change

+3.43%
ARAY price is up +3.43% today

Price YTD change

-23.73%
ARAY price is down -23.73% since January 1st

Price 1-year change

-33.77%
ARAY price is down -33.77% year-on-year

Price 3-year change

-53.82%
ARAY price is down -53.82% over the past 3 years

Price Range

Price All-time high

$31.09
ARAY price is currently -95.14% below its historical high of $31.09

Price 3-year low

$1.40
ARAY price is currently +7.86% above its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

$155.28M
ARAY market capitalization is $155.28 million

Market cap 3-year change

-48.83%
ARAY market capitalization is down -48.83% over the past 3 years

Market cap All-time high

$1.47B
ARAY market capitalization is currently -89.45% below its historical high of $1.47 billion

Market cap sector rank

53.9%
ARAY market capitalization is higher than 53.9% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+3.61%
ARAY shares outstanding is up +3.61% year-on-year

Shares Outstanding 3-Year Change

+10.81%
ARAY shares outstanding is up +10.81% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

1.64
ARAY beta is 1.64

200-day SMA

$1.94
ARAY price is currently -22.23% below its 200-day simple moving average

50-day SMA

$1.96
ARAY price is currently -22.98% below its 50-day simple moving average

RSI

27.80
ARAY 14-day relative strength index is 27.80

Volume

1.35
ARAY 30-day relative volume is 1.35

ATR

$0.11
ARAY average true range is $0.11

10-day Historical Volatility

61.83%
ARAY 10-day historical volatility is 61.83%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$446.55M
ARAY annual revenue is $446.55 million

Revenue Analysts estimate

$468.30M
ARAY annual revenue is currently -4.64% lower than the consensus analysts' forecast

Revenue 1-year change

-0.24%
ARAY annual revenue is down -0.24% year-on-year

Revenue Sector rank

73.12%
ARAY annual revenue is higher than 73.12% of companies in Healthcare sector

EPS

EPS

-$0.16
ARAY annual earnings per share is -$0.16

EPS Analysts estimate

-$0.02
ARAY annual earnings per share is currently +700.00% higher than the consensus analysts' forecast

EPS 1-year change

-60%
ARAY annual earnings per share is down -60% year-on-year

EPS Sector rank

79.11%
ARAY annual earnings per share is higher than 79.11% of companies in Healthcare sector

Profit

Gross profit

$142.92M
ARAY annual gross profit is $142.92 million

Gross margin

32.01%
ARAY annual gross profit margin is 32.01%

Operating profit

$504.00K
ARAY annual operating income is $504.00 thousand

Operating margin

0.11%
ARAY annual operating profit margin is 0.11%

Net income

-$15.54M
ARAY annual net profit is -$15.54 million

Net margin

-3.48%
ARAY annual net profit margin is -3.48%

Expenses

Total expenses

$446.05M
ARAY annual total expenses is $446.05 million

Operating expenses

$142.42M
ARAY annual total operating expenses is $142.42 million

Cost of goods sold

$303.63M
ARAY annual cost of goods sold is $303.63 million

Selling, general & administrative expenses

$92.69M
ARAY annual SGA is $92.69 million

Depreciation and amortization

$5.91M
ARAY annual depreciation & amortization is $5.91 million

Interest expense

$11.62M
ARAY annual interest expense is $11.62 million

Income tax

$3.73M
ARAY annual income tax is $3.73 million

EBIT & EBITDA

EBIT

$504.00K
ARAY annual earnings before interest & taxes is $504.00 thousand

EBITDA

$504.00K
ARAY annual EBITDA is $504.00 thousand

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$468.63M
ARAY annual total assets is $468.63 million

Non current assets

$145.39M
ARAY annual long term assets is $145.39 million

Current assets

$323.24M
ARAY annual total current assets is $323.24 million

Cash and cash equivalents

$68.57M
ARAY annual cash & cash equivalents is $68.57 million

Accounts receivable

$92.00M
ARAY annual accounts receivable is $92.00 million

Inventory

$138.32M
ARAY annual inventory is $138.32 million

Liabilities

Total liabilities

$423.54M
ARAY annual total liabilities is $423.54 million

Long term liabilities

$228.28M
ARAY annual total long term liabilities is $228.28 million

Current liabilities

$195.27M
ARAY annual total current liabilities is $195.27 million

Accounts payable

$50.02M
ARAY annual accounts payable is $50.02 million

Debt

Total debt

$210.75M
ARAY annual total debt is $210.75 million

Total debt 1-year change

+2.79%
ARAY annual total debt is up +2.79% year-on-year

Long term debt

$196.77M
ARAY annual long term debt is $196.77 million

Short term debt

$13.97M
ARAY annual short term debt is $13.97 million

Equity & Capital

Shareholders equity

$45.08M
ARAY annual stockholders equity is $45.08 million

Book value

$45.08M
ARAY annual book value is $45.08 million

Retained earnings

-$517.68M
ARAY annual retained earnings is -$517.68 million

Working capital

$127.97M
ARAY annual working capital is $127.97 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$11.90M
ARAY annual cash flow from operations is -$11.90 million

Cash from operations 1-year change

-176.61%
ARAY annual cash flow from operations is down -176.61% year-on-year

Cash from investing

-$3.60M
ARAY annual cash flow from investing activities is -$3.60 million

Cash from investing 1-year change

+71.6%
ARAY annual cash flow from investing activities is up +71.6% year-on-year

Cash from financing

-$3.95M
ARAY annual cash flow from financing activities is -$3.95 million

Cash from financing 1-year change

-87.07%
ARAY annual cash flow from financing activities is down -87.07% year-on-year

CAPEX

CAPEX

$3.60M
ARAY annual capital expenditures is $3.60 million

CAPEX 1-year change

-71.6%
ARAY annual capital expenditures is down -71.6% year-on-year

Free Cash Flow

Free cash flow

-$15.51M
ARAY annual free cash flow is -$15.51 million

Free cash flow 1-year change

-642.51%
ARAY annual free cash flow is down -642.51% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

32.01%
ARAY annual gross profit margin is 32.01%

Operating margin

0.11%
ARAY annual operating profit margin is 0.11%

Net margin

-3.48%
ARAY annual net profit margin is -3.48%

ROA & ROE

ROA

-3.28%
ARAY annual return on assets is -3.28%

ROE

-31.49%
ARAY annual return on equity is -31.49%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ARAY price to earnings ratio value is unknown

PE ratio Sector rank

-
ARAY price to earnings ratio is unknown

PB Ratio

PB ratio

3.24
ARAY price to book ratio is 3.24

PB ratio Sector rank

73.6%
ARAY price to book ratio is higher than 73.6% of companies in Healthcare sector

PS Ratio

PS ratio

0.34
ARAY price to sales ratio is 0.34

PS ratio Sector rank

11.28%
ARAY price to sales ratio is higher than 11.28% of companies in Healthcare sector

Enterprise value

Enterprise value

$306.19M
ARAY enterprise value is $306.19 million

Enterprise value Sector rank

63.5%
ARAY enterprise value is higher than 63.5% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

19.67
ARAY EV/EBITDA is 19.67

EV/EBITDA Sector rank

91.4%
ARAY EV/EBITDA is higher than 91.4% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

1.66
ARAY annual current ratio is 1.66

Quick ratio

0.95
ARAY annual quick ratio is 0.95

Leverage

Debt to equity

3.82
ARAY annual debt to equity ratio is 3.82

Interest coverage ratio

0.04
ARAY annual interest coverage ratio is 0.04

Risk & Stability

Piotroski F-Score

4
ARAY piotroski f-score is 4

Altman Z-Score

-0.04
ARAY altman z-score is -0.04

Analyst ratings

Recent major analysts updates

Feb 13, 24 Roth MKM
Buy
Oct 4, 23 B. Riley Securities
Buy
Aug 31, 22 B. Riley Securities
Buy
Jun 24, 22 BTIG
Buy
Jun 23, 22 B. Riley Securities
Buy
Dec 22, 21 Loop Capital
Buy
Jan 21, 20 BTIG Research
Buy
Jan 21, 20 BTIG
Buy
Nov 1, 18 Citigroup
Neutral
Aug 17, 18 Citigroup
Sell

Institutional Ownership

Similar stocks

OPRX logo
OptimizeRx (OPRX)
Actuate Therapeutics (ACTU)
RZLT logo
Rezolute (RZLT)
MASS logo
908 Devices (MASS)
DMAC logo
DiaMedica Therapeutics (DMAC)
MYO logo
Myomo (MYO)
TNGX logo
Tango Therapeutics (TNGX)
CGC logo
Canopy Growth (CGC)
IRWD logo
Ironwood Pharmaceuticals (IRWD)
  • What is the ticker symbol for Accuray Incorporated?
  • Does Accuray Incorporated pay dividends?
  • What sector is Accuray Incorporated in?
  • What industry is Accuray Incorporated in?
  • What country is Accuray Incorporated based in?
  • When did Accuray Incorporated go public?
  • Is Accuray Incorporated in the S&P 500?
  • Is Accuray Incorporated in the NASDAQ 100?
  • Is Accuray Incorporated in the Dow Jones?
  • When was Accuray Incorporated's last earnings report?
  • When does Accuray Incorporated report earnings?
  • Should I buy Accuray Incorporated stock now?

What is the ticker symbol for Accuray Incorporated?

The ticker symbol for Accuray Incorporated is NASDAQ:ARAY

Does Accuray Incorporated pay dividends?

No, Accuray Incorporated does not pay dividends

What sector is Accuray Incorporated in?

Accuray Incorporated is in the Healthcare sector

What industry is Accuray Incorporated in?

Accuray Incorporated is in the Medical Devices industry

What country is Accuray Incorporated based in?

Accuray Incorporated is headquartered in United States

When did Accuray Incorporated go public?

Accuray Incorporated's initial public offering (IPO) was on February 8, 2007

Is Accuray Incorporated in the S&P 500?

No, Accuray Incorporated is not included in the S&P 500 index

Is Accuray Incorporated in the NASDAQ 100?

No, Accuray Incorporated is not included in the NASDAQ 100 index

Is Accuray Incorporated in the Dow Jones?

No, Accuray Incorporated is not included in the Dow Jones index

When was Accuray Incorporated's last earnings report?

Accuray Incorporated's most recent earnings report was on Feb 5, 2025

When does Accuray Incorporated report earnings?

The next expected earnings date for Accuray Incorporated is May 1, 2025

Should I buy Accuray Incorporated stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page